Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 136
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03329989 | Safety and Effectiveness of EN3835 in the Treatment of EFP in Women | ||
| NCT01316874 | Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | ||
| NCT00904540 | Topical Lidocaine Patch in Low Back Pain | ||
| NCT01685437 | A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease | ||
| NCT02267460 | An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease | ||
| NCT05249257 | Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity | ||
| NCT03767452 | Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response | ||
| NCT00891163 | Evaluate the Depth and Duration of Anesthesia | ||
| NCT03120351 | Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery | ||
| NCT00370981 | Exploratory Study of Pagoclone in Men With Premature Ejaculation. | ||
| NCT00226395 | Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain | ||
| NCT02724644 | EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT03518034 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men | ||
| NCT03446781 | Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women | ||
| NCT01689896 | Testosterone and Pain Sensitivity | ||
| NCT01460654 | Testosterone and Alendronate in Hypogonadal Men | ||
| NCT00846495 | Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT00589979 | Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee | ||
| NCT00904098 | Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine | ||
| NCT01483963 | AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT00904020 | A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain | ||
| NCT00904085 | Post-operative Efficacy and Safety Study | ||
| NCT00904280 | Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy | ||
| NCT00904462 | Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee | ||
| NCT01518907 | The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT01383954 | The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis | ||
| NCT00700128 | Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals | ||
| NCT00414453 | Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis | ||
| NCT04580303 | CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques | ||
| NCT03893890 | Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT00904397 | Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain | ||
| NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | ||
| NCT01314664 | A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) | ||
| NCT00913055 | Open Label Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT00754611 | The Evolution and Management of Migraine Recurrence Beyond 24 Hours | ||
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | ||
| NCT00884715 | Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome | ||
| NCT00533273 | Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | ||
| NCT00528840 | Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT00644033 | A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine | ||
| NCT04236635 | Histopathology Following CCH Injection | ||
| NCT01221623 | Study of AA4500 in the Treatment of Peyronie's Disease | ||
| NCT04677712 | Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite | ||
| NCT01228071 | Time to Eugonadal Range, Time to Steady State and Drying Time | ||
| NCT01674634 | Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures | ||
| NCT04607187 | Ultrasound B Mode Imaging and Elastography | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT01444729 | Post Approval Commitment Study |
